This activity was originally presented at the 2026 Diabetes Day of Education.
Program Description
The management of diabetes has been transformed by the use of continuous glucose monitoring (CGM) devices, which are technologies that can provide a comprehensive understanding of time-in-range and glycemic variability. Pharmacists and pharmacy technicians must be familiar with these CGM devices and the information they provide. The true clinical value of these devices lies in the ability to interpret complex data trends rather than viewing isolated numbers. For community pharmacists, the ability to interpret these data trends is becoming a vital skill for identifying hidden patterns of hypoglycemia and hyperglycemia that may be less recognizable through standard blood glucose testing methods. This session dives into the latest digital tools and data features in CGM apps that can be leveraged by both people living with diabetes and pharmacists to support glycemic targets. The emerging frontier of continuous ketone monitoring (CKM) and its role in preventing diabetic ketoacidosis episodes will also be discussed. Speakers will review how integrated lifestyle management can be used alongside CGM data trends to individualize diabetes care and management. By mastering these digital therapeutics and CGM alerts, pharmacists and pharmacy technicians will gain the practical expertise needed to support patient education, troubleshoot potential concerns, and drive better results through proactive, real-time intervention.
Target audience: Community pharmacists and pharmacy technicians
Type of activity: Application
Release date: May 22, 2026
Expiration date: May 22, 2027
Learner level: Intermediate, Foundational
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, pharmacists will be able to:
- Differentiate the indications, benefits, limitations, and potential challenges associated with the use of continuous glucose monitoring (CGM) devices in diabetes management
- Use CGM data to identify trends, patterns, and the effectiveness of current treatment regimens
- Personalize patient education to guide real-time action and prevent adverse clinical outcomes, including hyperglycemia, hypoglycemia, and diabetic ketoacidosis

Susan Cornell, PharmD, CDCES, FAPhA, FADCES
Professor Emeritus
Experiential Education Specialist
Midwestern University College of Pharmacy
Downers Grove, IL
Clinical Pharmacist / Diabetes Care and Education Specialist
Bolingbrook Christian Health Center
Bolingbrook, IL
Clinical Pharmacist / Diabetes Care and Education Specialist
Will-Grundy Medical Clinic
Joliet, IL

Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES
Program Manager
Outpatient CDCES Staff
Teen Transition Program Coordinator
Diabetes Technology Specialist
University of Chicago Medicine
Sections of Adult and Pediatric Endocrinology
Chicago, IL

Accreditation
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-26-149-H01-P and 0290-0000-26-149-H01-T. The activity is available for CE credit through May 22, 2027.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Faculty
Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with ineligible companies to disclose:
Speakers Bureau: Boehringer Ingelheim
Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES, has the following relevant financial relationships with ineligible companies to disclose:
Consultant: Association of Diabetes Care and Education Specialists
Speakers Bureau: Abbott Diabetes Care, Insulet, Sanofi, Xeris
The following contributors have no relevant financial relationships with ineligible companies to disclose:
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Liza Patel, PharmD; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta.
Any relevant financial relationships listed for these individuals have been mitigated.
At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.
Educational Disclaimer
Continuing professional education activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved by the labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
